You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

New Vaccine Shows High Efficacy Against Malaria in Clinical Trial

HeadlineSep 09, 2022

Public health experts are hailing a new malaria vaccine after it showed 80% efficacy at preventing the disease in a clinical trial of children in Burkina Faso. The vaccine was produced by researchers at the University of Oxford, who published their results in the British medical journal The Lancet this week. The vaccine is relatively cheap and easy to produce, and the world’s largest vaccine manufacturer, the Serum Institute of India, says it can produce at least 200 million doses annually. Malaria is among the world’s deadliest infectious diseases, and the mosquito that carries it has been described as the “world’s deadliest animal.” In 2020, more than 640,000 people died of malaria — the vast majority of them in Africa.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation